Potentially Serious Drug Interactions Resulting From the Pretravel Health Encounter
Author(s) -
Nadine Sbaih,
Brian Buss,
Dheeraj Goyal,
Sowmya R. Rao,
Russell J Benefield,
Allison Taylor Walker,
Douglas H. Esposito,
Edward T. Ryan,
Regina C. LaRocque,
Daniel T. Leung,
George M. Abraham,
Salvador Álvarez,
Ver Ansdell,
Johnnie Yates,
Elisha H Atkins,
Holly K Birich,
Dagmar Vitek,
John Cahill,
Chen Lin,
Bradley A. Connor,
Roberta Dismukes,
Jessica K. Fairley,
Phyllis E. Kozarsky,
Henry M. Wu,
Ronke Dosunmu,
Jeffrey A Goad,
Edith Mirzaian,
Karl Hess,
Noreen A. Hynes,
Frédérique Jacquérioz,
Susan McLellan,
Jenn Katsolis,
Paul Kelly,
Mark Knouse,
Jennifer Lee,
B. Kendall,
DeVon C. Hale,
Alawode Oladele,
Hanna B. Demeke,
Althea Otuata,
Roger Pasinski,
Amy Wheeler,
Adrienne Showler,
Laura Coster,
Jessica Rosen,
Brian S. Schwartz,
William M. Stauffer,
Patricia Walker,
Joseph M. Vinetz
Publication year - 2018
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofy266
Subject(s) - medicine , pathogenic organism , drug , environmental health , pharmacology , microbiology and biotechnology , biology
Travelers seen for pretravel health encounters are frequently prescribed new travel-related medications, which may interact with their previously prescribed medications. In a cohort of 76 324 travelers seen at 23 US clinics, we found that 2650 (3.5%) travelers were prescribed travel-related medications with potential for serious drug interactions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom